Drug Type Small molecule drug |
Synonyms IDL 2965 |
Target |
Mechanism αvβ1 inhibitors(Integrin alpha-V/beta-1 inhibitors), αvβ3 antagonists(Integrin alpha-V/beta-3 antagonists), αvβ6 antagonists(Integrin alpha-V/beta-6 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Phase 2 | US | - | 11 Apr 2019 |
Nonalcoholic Steatohepatitis | Phase 2 | US | 29 Mar 2019 |